These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

513 related articles for article (PubMed ID: 38500373)

  • 1. Targeting Cell Senescence and Senolytics: Novel Interventions for Age-Related Endocrine Dysfunction.
    Suda M; Paul KH; Tripathi U; Minamino T; Tchkonia T; Kirkland JL
    Endocr Rev; 2024 Sep; 45(5):655-675. PubMed ID: 38500373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Senolytics and senomorphics: Natural and synthetic therapeutics in the treatment of aging and chronic diseases.
    Lagoumtzi SM; Chondrogianni N
    Free Radic Biol Med; 2021 Aug; 171():169-190. PubMed ID: 33989756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting cellular senescence with senotherapeutics: senolytics and senomorphics.
    Zhang L; Pitcher LE; Prahalad V; Niedernhofer LJ; Robbins PD
    FEBS J; 2023 Mar; 290(5):1362-1383. PubMed ID: 35015337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging Therapeutic Approaches to Target the Dark Side of Senescent Cells: New Hopes to Treat Aging as a Disease and to Delay Age-Related Pathologies.
    Khalil R; Diab-Assaf M; Lemaitre JM
    Cells; 2023 Mar; 12(6):. PubMed ID: 36980256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular senescence in bone.
    Farr JN; Khosla S
    Bone; 2019 Apr; 121():121-133. PubMed ID: 30659978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A guide to senolytic intervention in neurodegenerative disease.
    Lee S; Wang EY; Steinberg AB; Walton CC; Chinta SJ; Andersen JK
    Mech Ageing Dev; 2021 Dec; 200():111585. PubMed ID: 34627838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Senescent Cells: A Therapeutic Target in Cardiovascular Diseases.
    Suda M; Paul KH; Minamino T; Miller JD; Lerman A; Ellison-Hughes GM; Tchkonia T; Kirkland JL
    Cells; 2023 May; 12(9):. PubMed ID: 37174697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. National Institute on Aging Workshop: Repurposing Drugs or Dietary Supplements for Their Senolytic or Senomorphic Effects: Considerations for Clinical Trials.
    Romashkan S; Chang H; Hadley EC
    J Gerontol A Biol Sci Med Sci; 2021 May; 76(6):1144-1152. PubMed ID: 33528569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strategies for late phase preclinical and early clinical trials of senolytics.
    Wissler Gerdes EO; Misra A; Netto JME; Tchkonia T; Kirkland JL
    Mech Ageing Dev; 2021 Dec; 200():111591. PubMed ID: 34699859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Senolytic drugs: from discovery to translation.
    Kirkland JL; Tchkonia T
    J Intern Med; 2020 Nov; 288(5):518-536. PubMed ID: 32686219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular senescence and senolytics: the path to the clinic.
    Chaib S; Tchkonia T; Kirkland JL
    Nat Med; 2022 Aug; 28(8):1556-1568. PubMed ID: 35953721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential Use of Senolytics for Pharmacological Targeting of Precancerous Lesions.
    Saleh T; Carpenter VJ
    Mol Pharmacol; 2021 Dec; 100(6):580-587. PubMed ID: 34544896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application potential of senolytics in clinical treatment.
    Li T; Li S; Ma K; Kong J
    Biogerontology; 2024 Jun; 25(3):379-398. PubMed ID: 38109001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Obesity, Senescence, and Senolytics.
    Chaib S; Tchkonia T; Kirkland JL
    Handb Exp Pharmacol; 2022; 274():165-180. PubMed ID: 34697668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of cellular senescence in ageing and endocrine disease.
    Khosla S; Farr JN; Tchkonia T; Kirkland JL
    Nat Rev Endocrinol; 2020 May; 16(5):263-275. PubMed ID: 32161396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Senolytic and senomorphic interventions to defy senescence-associated mitochondrial dysfunction.
    Nehlin JO
    Adv Protein Chem Struct Biol; 2023; 136():217-247. PubMed ID: 37437979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging roles of senolytics/senomorphics in HIV-related co-morbidities.
    Kaur G; Sohanur Rahman M; Shaikh S; Panda K; Chinnapaiyan S; Santiago Estevez M; Xia L; Unwalla H; Rahman I
    Biochem Pharmacol; 2024 Oct; 228():116179. PubMed ID: 38556028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential Clinical Implications of Senotherapies for Cardiovascular Disease.
    Suda M; Katsuumi G; Tchkonia T; Kirkland JL; Minamino T
    Circ J; 2024 Feb; 88(3):277-284. PubMed ID: 37880106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in targeted therapies for age-related osteoarthritis: A comprehensive review of current research.
    Zhang Y; Zhou Y
    Biomed Pharmacother; 2024 Oct; 179():117314. PubMed ID: 39167845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitochondria-targeted senotherapeutic interventions.
    Atayik MC; Çakatay U
    Biogerontology; 2022 Aug; 23(4):401-423. PubMed ID: 35781579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.